Conditions: Major Depressive Disorder
Keywords: depression major depressive disorder escitalopram Lexapro pediatric
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 162
Healthy volunteers: no

Brief summary:
This study will evaluate the long-term safety and tolerability of escitalopram (Lexapro) in children 7 to 11 years of age with major depressive disorder (MDD).

Detailed description:

Arms:
arm 1: Flexible-dose 10mg-20mg once-daily oral (10mg tablets) dose of escitalopram

Interventions: intervention 1: Escitalopram
Intervention descriptions: intervention 1: Patients who meet eligibility criteria will receive open-label escitalopram. 10-20mg oral administration (10mg tablets) once daily for 24-weeks with a 2-week downtaper period.

Protocol document: